5 Personalized Medicine Stocks Billionaires Are Loading Up On

4. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Billionaire Investors: 15

Dollar Value of Billionaire Holdings: $477,264,538

Number of Hedge Fund Holders: 69

Bristol-Myers Squibb Company (NYSE:BMY) is at the fourth position on our list of the best personalized medicine stocks billionaires are purchasing.

In August 2022, Bristol Myers Squibb (NYSE:BMY) acquired Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a precision oncology company, for $76 per share. Bristol-Myers Squibb Company (NYSE:BMY) made the acquisition of Turning Point Therapeutics, Inc. (NASDAQ:TPTX) to enhance its position in the field of precision oncology.